))
A high-ranking BD executive is set to retire; J&J’s Biosense Webster begins trial for Laminar LAA
Manage episode 403596345 series 3481361
Content provided by Fast Five by MassDevice. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Fast Five by MassDevice or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Welcome to the MassDevice Fast Five medtech news podcast, the show that keeps you up-to-date on the latest breakthroughs in medical technology. Here’s what you need to know for today, February 28, 2024. Check out the show notes for links to the stories we discussed today at MassDevice.com/podcast. Mainstay Medical has raised $125 million for its neurostimulation technology. Fast Five hosts Danielle Kirsh and Sean Whooley talk about the company's plans for the funds and what the implant does. Philips has launched its new Azurion neuro biplane system for neurovascular interventions. Learn more about what Azurion does and how it helps workflows. Know Labs unveiled its wearable, non-invasive CGM set for FDA submission. Whooley details the technology and how it works. J&J's Biosense Webster has started its trial for the recently acquired Laminar left atrial appendage elimination device. Hear more about the study details and an explanation of what Laminar is. A high-ranking executive at BD has announced plans to retire. The Fast Five hosts talk about who is leaving, if the company named a successor and some of the work the executive has achieved in their tenure.
…
continue reading
161 episodes
Share
